Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-09-17 00:00:00 ET · period of report 2024-09-13 · accession 0000950170-24-107391 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-17 | 2024-09-13 | TYRA | Fuhrman Alan | CFO | A - Grant | $12.48 | +954 | 3,349 | +40% | +$11.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-13 | A | A | 954 | $12.48 | 3,349 | D | — | — |